643 results
Page 6 of 33
8-K
EX-99.1
fj3ojt x5k8y0j
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
8-K
EX-99.1
69b833l2cdqud8 gu6sa
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm
8-K
6dp518xge7p9b4du0skp
22 Mar 19
Departure of Directors or Certain Officers
4:22pm
8-K
k1fhfzmtvk 0nqeyqf1
31 Jan 19
Departure of Directors or Certain Officers
5:28pm
8-K
o66pe9jqlwtj y8
3 Jan 19
Regulation FD Disclosure
7:03am
8-K
41m nyorx7a7y
31 Dec 18
Departure of Directors or Certain Officers
4:55pm
8-K
EX-10.3
luqwbqxg ko
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
8-K
EX-99.1
hhk j8w3np
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
8-K
EX-10.1
7xk vucx58hgux6yjm
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
8-K
6dir0eogi1widr
14 Dec 18
Departure of Directors or Certain Officers
4:25pm
8-K
1im3e5kx 882f
7 Dec 18
Entry into a Material Definitive Agreement
5:02pm
8-K
aavdy2gni
7 Dec 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
a4o74 7f1e4kyao
7 Dec 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
jlbd1q1 la
23 Nov 18
Entry into a Material Definitive Agreement
4:03pm